Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rägo

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|October 24, 2007
Access to essential medicines for children: the world health organization's global responseH Zucker, L Rägo
Trends in Pharmacological Sciences|March 1, 1988
Does biology duplicate itself?M Zilmer, L Rägo
European Journal of Pharmacology|October 23, 1990
[3H]Ro 5-4864 binding sites in the nucleus of rat lymphocytesL Rägo, A Adojaan, R Masso
Neuroreport|January 14, 1998
Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in ratsA Kask, L Rägo, J Harro
Pharmacology & Therapeutics|January 1, 1989
Peripheral benzodiazepine binding sitesV Saano, L Rägo, M Räty
Regulatory Peptides|November 5, 1998
Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in ratsA Kask, L Rägo, J Harro
Pharmacological Research|July 1, 1996
Behavioural effects of pinoline in the rat forced swimming, open field and elevated plus-maze testsR Pähkla, J Harro, L Rägo
Pharmacology, Biochemistry, and Behavior|April 15, 2000
Differential effects of beta-carbolines and antidepressants on rat exploratory activity in the elevated zero-mazeR Pähkla, A Kask, L Rägo
British Journal of Pharmacology|September 2, 1998
Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226A Kask, L Rägo, J Harro
Neuroreport|October 6, 1998
NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction testA Kask, L Rägo, J Harro
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|October 24, 2007
Access to essential medicines for children: the world health organization's global responseH Zucker, L Rägo
Trends in Pharmacological Sciences|March 1, 1988
Does biology duplicate itself?M Zilmer, L Rägo
European Journal of Pharmacology|October 23, 1990
[3H]Ro 5-4864 binding sites in the nucleus of rat lymphocytesL Rägo, A Adojaan, R Masso
Neuroreport|January 14, 1998
Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in ratsA Kask, L Rägo, J Harro
Pharmacology & Therapeutics|January 1, 1989
Peripheral benzodiazepine binding sitesV Saano, L Rägo, M Räty
Regulatory Peptides|November 5, 1998
Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in ratsA Kask, L Rägo, J Harro
Pharmacological Research|July 1, 1996
Behavioural effects of pinoline in the rat forced swimming, open field and elevated plus-maze testsR Pähkla, J Harro, L Rägo
Pharmacology, Biochemistry, and Behavior|April 15, 2000
Differential effects of beta-carbolines and antidepressants on rat exploratory activity in the elevated zero-mazeR Pähkla, A Kask, L Rägo
British Journal of Pharmacology|September 2, 1998
Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226A Kask, L Rägo, J Harro
Neuroreport|October 6, 1998
NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction testA Kask, L Rägo, J Harro
Pageof 5